WALTER DEAN: Open Payments
NPI 1154499010 · MISSION, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,669 in 208 payments from 24 companies in 2025. Trend: 2023 $3,234 · 2024 $3,735 · 2025 $3,669
Food & beverage: $3,570Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $729 |
| Janssen Biotech, Inc. | 25 | $489 |
| PFIZER INC. | 18 | $287 |
| UCB, Inc. | 14 | $244 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $222 |
| Novartis Pharmaceuticals Corporation | 12 | $208 |
| Kerecis Limited | 12 | $186 |
| Lilly USA, LLC | 11 | $181 |
| MAYNE PHARMA COMMERCIAL LLC | 9 | $180 |
| Arcutis Biotherapeutics, Inc. | 19 | $161 |
Products named: TREMFYA, RINVOQ, CIBINQO, SKYRIZI, Bimzelx, DUPIXENT, Kerecis SurgiClose, TALTZ.
Industry payments across KS — which companies pay providers there.
